The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Johnson & Johnson (NYSE: JNJ) will present data from two major studies supporting the performance of its recently FDA-approved TECNIS PureSee intraocular lens (IOL) at the 2026 American Society of ...
Hosted on MSN
FDA approves Tecnis PureSee lens to cut glare risk
Johnson & Johnson has gained FDA approval for its Tecnis PureSee intraocular lens, the first extended depth-of-focus lens designed to maintain contrast sensitivity while minimizing glare and halos.
JACKSONVILLE, Fla., March 12, 2026--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results